Synergistic antitumor and immunomodulatory effects of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> V9 combined with anti-PD-1 therapy.

Front Immunol · 2026 · PMC13246658 · PMID 42273689

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

lactis V9 combined with αPD-1 therapy showed a trend of slowing tumor growth in both tumor models, suggesting that it may enhance the anti-tumor effects of immune checkpoint inhibitors.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Synergistic antitumor and immunomodulatory effects of &lt;i&gt;Bifidobacterium animalis&lt;/i&gt; subsp. &lt;i&gt;lactis&lt;/i&gt; V9 combined with anti-PD-1 therapy.

The sentences

Synergistic antitumor and immunomodulatory effects of <i>Bifidobacterium animalis</i> subsp. <i>lactis</i> V9 combined with anti-PD-1 therapy.